NDA/BLA filedconf 0.80

relacorilant — NDA/BLA filed

$CORT · CORCEPT THERAPEUTICS INC · hypertension secondary to hypercortisolism

Event date

Date TBD

Sponsor runway

5+ yrs

$338.2M liquid

Evidence

“the Company has submitted a new drug application to the U.S. Food and Drug Administration for its proprietary, selective cortisol modulator, relacorilant, to treat patients with endogenous hypercortisolism (Cushing's syndrome)”

Source: 8-K filed 2024-12-30View on EDGAR ↗0001193125-24-286917

Comparable historical nda/bla fileds· last 5 years · same indication

Ticker	Drug	Date	Outcome
$CORT	relacorilant	2025-03-03	unknown

Recent insider activity· ±90 days

6 insiders · 2 buys · 5 sells

Gift

2026-05-13

Robb Gary Charles

Chief Business Officer

1,000 @ ——

Gift

2026-05-13

Robb Gary Charles

Chief Business Officer

5,300 @ ——

Sell10b5-1

2026-05-05

Guyer William

Chief Development Officer

20,000 @ $51.83$1.04M

Exercise10b5-1

2026-05-05

Guyer William

Chief Development Officer

20,000 @ $21.65$433K

Sell10b5-1

2026-05-01

BELANOFF JOSEPH K

Chief Executive Officer

40,000 @ $50.10$2.00M

Gift

2026-04-22

WILSON JAMES N

Director

2,000 @ ——

Exercise10b5-1

2026-04-07

Guyer William

Chief Development Officer

20,000 @ $21.65$433K

Sell10b5-1

2026-04-07

Guyer William

Chief Development Officer

20,000 @ $40.97$819K

Gift

2026-04-06

WILSON JAMES N

Director

5,000 @ ——

Sell10b5-1

2026-03-25

BELANOFF JOSEPH K

Chief Executive Officer

26,198 @ $50.07$1.31M

Gift

2026-03-20

WILSON JAMES N

Director

4,000 @ ——

Exercise10b5-1

2026-03-20

Guyer William

Chief Development Officer

11,767 @ $21.65$255K

Sell10b5-1

2026-03-20

Guyer William

Chief Development Officer

11,767 @ $36.01$424K

Buy

2026-03-17

BAKER G LEONARD JR

Director

24,218 @ $33.56$813K

Buy

2026-03-17

BAKER G LEONARD JR

Director

75,782 @ $33.00$2.50M

Other

2026-03-13

MAHONEY DAVID L

Director

24,531 @ ——

Gift

2026-03-13

MAHONEY DAVID L

Director

24,531 @ ——

Tax

2026-03-13

MAHONEY DAVID L

Director

5,469 @ $32.15$176K

Exercise

2026-03-13

MAHONEY DAVID L

Director

30,000 @ $5.86$176K

Gift

2026-03-13

WILSON JAMES N

Director

28,000 @ ——

Date	Insider	Action	Shares	Price	Value
2026-05-13	Robb Gary CharlesChief Business Officer	Gift	1,000	—	—
2026-05-13	Robb Gary CharlesChief Business Officer	Gift	5,300	—	—
2026-05-05	Guyer WilliamChief Development Officer	Sell10b5-1	20,000	$51.83	$1.04M
2026-05-05	Guyer WilliamChief Development Officer	Exercise10b5-1	20,000	$21.65	$433K
2026-05-01	BELANOFF JOSEPH KChief Executive Officer	Sell10b5-1	40,000	$50.10	$2.00M
2026-04-22	WILSON JAMES NDirector	Gift	2,000	—	—
2026-04-07	Guyer WilliamChief Development Officer	Exercise10b5-1	20,000	$21.65	$433K
2026-04-07	Guyer WilliamChief Development Officer	Sell10b5-1	20,000	$40.97	$819K
2026-04-06	WILSON JAMES NDirector	Gift	5,000	—	—
2026-03-25	BELANOFF JOSEPH KChief Executive Officer	Sell10b5-1	26,198	$50.07	$1.31M
2026-03-20	WILSON JAMES NDirector	Gift	4,000	—	—
2026-03-20	Guyer WilliamChief Development Officer	Exercise10b5-1	11,767	$21.65	$255K
2026-03-20	Guyer WilliamChief Development Officer	Sell10b5-1	11,767	$36.01	$424K
2026-03-17	BAKER G LEONARD JRDirector	Buy	24,218	$33.56	$813K
2026-03-17	BAKER G LEONARD JRDirector	Buy	75,782	$33.00	$2.50M
2026-03-13	MAHONEY DAVID LDirector	Other	24,531	—	—
2026-03-13	MAHONEY DAVID LDirector	Gift	24,531	—	—
2026-03-13	MAHONEY DAVID LDirector	Tax	5,469	$32.15	$176K
2026-03-13	MAHONEY DAVID LDirector	Exercise	30,000	$5.86	$176K
2026-03-13	WILSON JAMES NDirector	Gift	28,000	—	—

← All catalysts for $CORT